Fifth Third Bancorp’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,832
Closed -$11.9K 2566
2023
Q4
$11.9K Buy
1,832
+1,647
+890% +$10.6K ﹤0.01% 1922
2023
Q3
$1.75K Sell
185
-38
-17% -$457 ﹤0.01% 2400
2023
Q2
$3.12K Buy
223
+84
+60% +$1.43K ﹤0.01% 2328
2023
Q1
$2.61K Hold
139
﹤0.01% 2508
2022
Q4
$1.91K Hold
139
﹤0.01% 2441
2022
Q3
$3K Hold
139
﹤0.01% 2375
2022
Q2
$2K Sell
139
-135
-49% -$2K ﹤0.01% 2478
2022
Q1
$6K Buy
274
+239
+683% +$4.87K ﹤0.01% 2274
2021
Q4
$1K Buy
+35
New +$1K ﹤0.01% 2648
2014
Q3
Sell
-13
Closed 2491
2014
Q2
$0 Buy
+13
New +$164 ﹤0.01% 2467

Other funds holding CDMO

Fifth Third Bancorp's CDMO Position: Q1 2024 in Review

Fifth Third Bancorp sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 1,832 shares — an estimated $11.9K sold.

Fifth Third Bancorp first reported a position in CDMO in Q2 2014 and held it in 10 quarters. The position peaked at $11.9K in Q4 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Fifth Third Bancorp reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,832 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $11.9K.
  • Fifth Third Bancorp first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
  • Fifth Third Bancorp's Avid Bioservices, Inc. Common Stock position peaked at $11.9K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Fifth Third Bancorp's 13F filing for Q1 2024, filed 23 Apr 2024.